Champions Oncology Inc Stock
Price
Target price
€5.35
€5.35
3.880%
0.2
3.880%
-
29.07.25 / Frankfurt
WKN: A14X6S / Name: Champions / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Champions Oncology Inc Stock
Champions Oncology Inc dominated the market today, gaining €0.20 (3.880%).
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
M***** P*******
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | 3.880% | -24.265% | -14.167% | 15.471% | 8.193% | -36.810% | -28.472% |
| Krystal Biotech | 0.990% | 1.895% | 11.088% | -30.603% | -13.436% | 84.266% | - |
| Ardelyx Inc. | 2.680% | -3.054% | 15.653% | -29.016% | -26.485% | 437.476% | -33.028% |
| Evolus Inc | -1.900% | -3.727% | 0.649% | -31.416% | -26.190% | -32.609% | 169.659% |
News
Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
Expanded offering delivers integrated radiopharmaceutical studies using clinically relevant isotopes and highly characterized PDX tumor models
HACKENSACK, NJ / ACCESS Newswire / July 8,
Sweden, the Czech Republic, and Greece Crowned Champions of Harm Reduction in Brussels
BRUSSELS, BE / ACCESS Newswire / July 3, 2025 / Brussels transformed into a Champions League pitch for tobacco harm reduction as the World Vapers' Alliance (WVA) honoured Sweden, the Czech